Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, ...

AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

Roche’s oral PI3K inhibitor Itovebi (inavolisib) has been approved by the European Commission (EC) as part of a combination ...

The National Institute for Health and Care Excellence (NICE) has recommended ALK’s once-daily immunotherapy tablet to target ...

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost ...

Tidmarsh has most recently been serving as adjunct professor of paediatrics and neonatology at Stanford University ...

Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...

Sanofi has announced that it will be expanding its respiratory vaccines pipeline by acquiring UK-based Vicebio for up to ...

Download the first edition of the Petauri ‘US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities’ report ...

Eli Lilly and Almirall’s Ebglyss (lebrikizumab) has been shown to significantly improve the signs and symptoms of atopic ...

Shared care models, supported by effective communication and digital tools, are helping community nurses like Ashleigh Tropp ...